Urology Center, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Pediatr Surg Int. 2021 Aug;37(8):1141-1146. doi: 10.1007/s00383-021-04925-y. Epub 2021 May 21.
The efficacy and safety of super-mini percutaneous nephrolithotomy (SMP, 14 Fr) was compared with mini percutaneous nephrolithotomy (MPCNL, 16 Fr) for the treatment of upper urinary tract stones in children (< 14 years old).
Clinical data of 133 paediatric patients with upper urinary tract stones treated with SMP or MPCNL between May 2012 and May 2019 were retrospectively analysed. The patients were divided into the SMP and MPCNL groups. Age, height, weight, stone size, operation time, stone-free rate (SFR), postoperative complications, tubeless rate, and length of postoperative hospital stay (LOS) were compared.
There were 66 patients (49.6%) in the SMP and 67 patients (50.4%) in the MPCNL group. No significant difference in the median age, weight, height and operation time, and SFR existed between the patients of the two groups. Larger stones were removed via SMP compared to those removed with MPCNL (2.0 vs. 1.5 cm, P = 0.001). LOS for SMP patients was significantly lower than that for the MPCNL patients (2 and 6 days, respectively, P < 0.0001). The tubeless rate for SMP was significantly higher than that for MPCNL (100% vs. 0%, P < 0.0001). Total complication rate of MPCNL was significantly higher than that of SMP (25.3% vs. 7.5%, P = 0.006). No patient required blood transfusion, and septicaemia, and other serious complications did not occur.
SMP is more effective than MPCNL for treating middle-sized upper urinary tract stones in children, and is associated with a shorter LOS and a higher tubeless rate.
比较超微经皮肾镜碎石术(SMP,14Fr)与微创经皮肾镜碎石术(MPCNL,16Fr)治疗儿童(<14 岁)上尿路结石的疗效和安全性。
回顾性分析 2012 年 5 月至 2019 年 5 月采用 SMP 或 MPCNL 治疗的 133 例儿童上尿路结石患者的临床资料。患者分为 SMP 组和 MPCNL 组。比较两组患者的年龄、身高、体重、结石大小、手术时间、结石清除率(SFR)、术后并发症、无管率及术后住院时间(LOS)。
SMP 组 66 例(49.6%),MPCNL 组 67 例(50.4%)。两组患者的中位年龄、体重、身高和手术时间、SFR 差异均无统计学意义。SMP 组取出的结石较大,而 MPCNL 组取出的结石较小(2.0 vs. 1.5cm,P=0.001)。SMP 组患者的 LOS 明显短于 MPCNL 组(分别为 2 天和 6 天,P<0.0001)。SMP 组的无管率明显高于 MPCNL 组(100% vs. 0%,P<0.0001)。MPCNL 组总并发症发生率明显高于 SMP 组(25.3% vs. 7.5%,P=0.006)。两组均未输血,无败血症等严重并发症发生。
SMP 治疗儿童中等大小上尿路结石较 MPCNL 更有效,LOS 更短,无管率更高。